Beijing Centergate Technologies: Notice on the receipt of the “Notice of Acceptance” of the subsidiary company Duoduo Pharmaceutical Ambroxol Hydrochloride Injection from the State Drug Administration

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.